These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 38032149)
1. Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma. Zhao S; Hu X; Zhou P; Li A; Chen L; Wang D; He J; Jiang Y Cancer Biol Ther; 2023 Dec; 24(1):2256927. PubMed ID: 38032149 [TBL] [Abstract][Full Text] [Related]
2. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma. Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915 [TBL] [Abstract][Full Text] [Related]
4. Correlation of PD-L1 expression with CD8+ T cells and oxidative stress-related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma. Zhang X; Yang Y; Zhao H; Tian Z; Cao Q; Li Y; Gu Y; Song Q; Hu X; Jin M; Jiang X J Pathol Clin Res; 2024 Jul; 10(4):e12390. PubMed ID: 38992928 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma. Hu J; Toyozumi T; Murakami K; Endo S; Matsumoto Y; Otsuka R; Shiraishi T; Iida S; Morishita H; Makiyama T; Nishioka Y; Uesato M; Hayano K; Nakano A; Matsubara H Cancer Med; 2024 Sep; 13(17):e70179. PubMed ID: 39264227 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
8. PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population. Rong L; Liu Y; Hui Z; Zhao Z; Zhang Y; Wang B; Yuan Y; Li W; Guo L; Ying J; Song Y; Wang L; Zhou Z; Xue L; Lu N Diagn Pathol; 2019 Jan; 14(1):6. PubMed ID: 30684971 [TBL] [Abstract][Full Text] [Related]
9. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma. Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma. Hatogai K; Kitano S; Fujii S; Kojima T; Daiko H; Nomura S; Yoshino T; Ohtsu A; Takiguchi Y; Doi T; Ochiai A Oncotarget; 2016 Jul; 7(30):47252-47264. PubMed ID: 27322149 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression. Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J Front Immunol; 2021; 12():798424. PubMed ID: 35145511 [TBL] [Abstract][Full Text] [Related]
12. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma. Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486 [TBL] [Abstract][Full Text] [Related]
13. CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer. Zhu Y; Li M; Mu D; Kong L; Zhang J; Zhao F; Li Z; Liu X; Bo C; Yu J Oncotarget; 2016 Nov; 7(44):71455-71465. PubMed ID: 27683115 [TBL] [Abstract][Full Text] [Related]
14. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer. Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475 [TBL] [Abstract][Full Text] [Related]
16. Vimentin, inversely correlating with infiltration of CD8 + T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma. Liang Y; He S; Liu Q; Liu T; Tan Y; Peng T; Huang C; Lu X; Zheng S Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119781. PubMed ID: 38901494 [TBL] [Abstract][Full Text] [Related]
17. Aligning digital CD8 Conde E; Caminoa A; Dominguez C; Calles A; Walter S; Angulo B; Sánchez E; Alonso M; Jimenez L; Madrigal L; Hernando F; Sanz-Ortega J; Jimenez B; Garrido P; Paz-Ares L; de Castro J; Hernandez S; Lopez-Rios F Histopathology; 2018 Jan; 72(2):270-284. PubMed ID: 28815764 [TBL] [Abstract][Full Text] [Related]
18. Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8⁺ T cells. Leng C; Li Y; Qin J; Ma J; Liu X; Cui Y; Sun H; Wang Z; Hua X; Yu Y; Li H; Zhang J; Zheng Y; Wang W; Zhu J; Wang Q Oncol Rep; 2016 Feb; 35(2):699-708. PubMed ID: 26718132 [TBL] [Abstract][Full Text] [Related]
19. Characterization of CD103 Han L; Gao QL; Zhou XM; Shi C; Chen GY; Song YP; Yao YJ; Zhao YM; Wen XY; Liu SL; Qi YM; Gao YF Cancer Immunol Immunother; 2020 Aug; 69(8):1493-1504. PubMed ID: 32285170 [TBL] [Abstract][Full Text] [Related]
20. Programmed cell death-ligand 1 expression predicts poor treatment response and prognostic value in esophageal squamous cell carcinoma patients without esophagectomy. Zhang F; Zhu X; Zhang Q; Zhou P; Hao L Aging (Albany NY); 2021 Jul; 13(14):18827-18838. PubMed ID: 34297698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]